Form 4: Arteris Inc. Director Sells Shares Under 10b5-1 Trading Plan

Director Saiyed Atiq Raza sold a total of 27,083 shares of Arteris, Inc. common stock in two transactions on December 17 and 18, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Saiyed Atiq Raza, a director at Arteris, Inc., sold 14,917 shares of common stock on December 17, 2024, at a weighted average price of $10.0068 per share.
• The shares were sold in multiple transactions with prices ranging from $10.00 to $10.09.
• On December 18, 2024, Mr. Raza sold an additional 12,166 shares at a weighted average price of $10.0749 per share.
• These shares were sold in multiple transactions with prices ranging from $10.00 to $10.35.
• The sales were executed under a 10b5-1 trading plan adopted on June 6, 2024.
• Following these transactions, Mr. Raza indirectly owns 731,560 shares through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of insider trading activity and does not indicate any positive or negative sentiment. The sales were pre-planned under a 10b5-1 plan.

Industry Context

This is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 trading plan indicates that the sales were pre-planned and not based on any material non-public information.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice for corporate insiders to avoid accusations of illegal insider trading.
• The reported share sales are typical for directors and officers of publicly traded companies.
• The price ranges of the sales are within a normal trading range for the stock.

Stakeholder Impact

• The share sales may have a minor impact on the stock price, but the pre-planned nature of the transactions should mitigate any significant effect.

Key Dates

Keywords

Arteris, insider trading, Form 4, stock sale, 10b5-1 plan, Saiyed Atiq Raza, director